• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

How to get the gain without the pain in shift to 3T MR

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 5
Volume 32
Issue 5

With its add-on software and higher performance coils, field-upgradeable MR scanners are the lifeblood of the imaging community. But systems with upgradeable fields are rare.

With its add-on software and higher performance coils, field-upgradeable MR scanners are the lifeblood of the imaging community. But systems with upgradeable fields are rare.

Philips Healthcare debuted the idea at RSNA 2006, touting its Achieva XR as the first and, so far, only 1.5T product that can be upgraded in the field to 3T. Thirty-nine of these multifield systems have been put in place since the device's unveiling. Philips argued that its Achieva XR can serve as a kind of insurance policy against obsolescence. Customers not ready to take the leap to 3T, Philips said, can use the Achieva XR at 1.5T indefinitely with the assurance that a higher field strength is just an upgrade away.

MetroHealth bought the scanner but not the argument. The 500-bed hospital ran its Achieva XR at 1.5T for only a month before ramping it to 3T. The idea was to teach staff the new Philips interface using a familiar field strength.

“We had some reservations about making this double jump, going to a new platform and going to 3T, so this offered us the opportunity to ease into it,” said Pedro Diaz, Ph.D., vice chair of imaging and informatics systems at MetroHealth.

Replacing its existing 1.5T scanner with the new Achieva XR spanned several weeks, according to Diaz. But the transition from 1.5T to 3T was done in a few days.

Scanning at 3T then began with the same user interface as at 1.5T, using the same patient setup, same coils, and, consequently, the same knowledge base. What staff had learned to do at 1.5T was applicable at 3T, Diaz said.

“Philips did a really good job of helping us find the replacement sequences for 3T,” he said.

Typically sites making this jump must compare images at the two field strengths taken on wholly different machines, possibly from different vendors. The Achieva XR provided MetroHealth the opportunity to directly compare 1.5T and 3T images taken under conditions that differed only in field strength. This baseline allowed staff to determine which patients are best imaged on the 3T Achieva and which on the 1.5T Philips scanner, also newly acquired.

The only cases now going automatically to 3T at MetroHealth are the obvious ones: spectroscopy, diffusion tensor imaging, and functional imaging. High-resolution brain angiography is done, when warranted, at 3T. Conversely, body MR scans that Diaz thought could be done only on the 1.5T machine because of artifacts typically associated with 3T, can, in fact, be done on the higher field scanner.

Both machines can handle routine scans. Achieva XR offers advantages in speed, due to the improved signal-to-noise ratio available at 3T, with the option of trading speed for better resolution. This kind of interchangeability was the goal behind MetroHealth's transition to two Philips high-field scanners.

“One of our fears was that everyone would want to have every patient done at 3T,” Diaz said. “The way we did it allowed us to make convincing arguments about what really absolutely needed to be done at 3T.”

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.